Endovia Health
EDVA

Endovia Health (EDVA) earnings history

Most recent quarter

Period end
Sep 30, 2024
EPS actual
−$12.80
EPS estimate
−$12.80
Revenue
$981,858.00
Reported
Nov 15, 2024

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2024Nov 15, 2024−$12.80−$12.80+0.00%$981,858.00SEC
Q2 2024Aug 14, 2024−$14.40−$17.60−22.22%$1.0MSEC
Q4 2023Mar 29, 2024−$16.00−$18.40−15.00%$2.7MSEC
Q3 2023Nov 14, 2023−$18.40−$20.80−13.04%$5.1MSEC
Q2 2023Aug 14, 2023−$17.60−$20.80−18.18%$5.2MSEC
Q1 2023Jun 6, 2023−$19.20−$24.00−25.00%$5.8MSEC
Q4 2022Mar 31, 2023−$22.40−$20.00+10.71%$4.8MSEC
Q3 2022Nov 14, 2022−$8.00−$20.80−160.00%$5.0M
Q2 2022Aug 15, 2022−$8.00−$25.60−220.00%$4.5M
Q4 2021Mar 31, 2022$0.00−$30.40+0.00%$2.8M
Q3 2021Nov 15, 2021$0.00−$99.20+0.00%$2.8M

Quarterly revenue

Q3 2021
$2.8M
Q4 2021
$2.8M
Q2 2022
$4.5M
Q3 2022
$5.0M
Q4 2022
$4.8M
Q1 2023
$5.8M
Q2 2023
$5.2M
Q3 2023
$5.1M
Q4 2023
$2.7M
Q2 2024
$1.0M
Q3 2024
$981,858.00

Frequently asked questions

  • When did Endovia Health (EDVA) last report earnings?

    Endovia Health last reported on Nov 15, 2024, covering fiscal Q3 2024.

  • Did EDVA beat earnings estimates?

    Endovia Health reported EPS of −$12.80 for Q3 2024, in line with the −$12.80 consensus estimate.

  • How much revenue did EDVA report last quarter?

    Endovia Health reported $981,858.00 in revenue for Q3 2024, against a consensus estimate of $2.1M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.